Hypercalcemia of Malignancy
Author: Friedhelm Raue
Publisher: Springer Science & Business Media
Published: 2012-12-06
Total Pages: 238
ISBN-13: 3642850731
DOWNLOAD EBOOKHypercalcemia is the most common life-threatening metabolic disorder associated with cancer. The pathophysiological, epidemiological and clinical aspects of hypercalcemia of malignancy are presented in this issue, with a focus on the recently discovered humoral factor responsible for the development of hypercalcemia. With a better understanding of the pathophysiology of this condition and the development of new potent drugs, capable of inhibiting bone resorption, especially bisphosphonates, the clinician will be more successful in correcting hypercalcemia in the great majority of patients.